Skip to Main Content

Author Details

Takuro Nakamura
Tohoku University Graduate School of Medicine
1987
179
40
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36660940Antitumor activities of a defucosylated antiâ¿¿EpCAM monoclonal antibody in colorectal carcinoma xenograft models.Int J Mol Med2023
37212282HEY1-NCOA2 expression modulates chondrogenic differentiation and induces mesenchymal chondrosarcoma in mice.JCI Insight2023
36967299Targeting epigenetic aberrations of sarcoma in CRISPR era.Genes Chromosomes Cancer2023
37029109ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma.Nat Commun2023
36959380Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.Br J Cancer2023
36860189Clinicopathologic and genetic characterization of angiofibroma of soft tissue: a study of 12 cases including two cases with AHRR::NCOA3 gene fusion.Histopathology2023
34714913BCL11A promotes myeloid leukemogenesis by repressing PU.1 target genes.Blood Adv2022
35471052C<sub>8</sub>Mab-2: An Anti-Mouse C-C Motif Chemokine Receptor 8 Monoclonal Antibody for Immunocytochemistry.Monoclon Antib Immunodiagn Immunother2022
36202860Small round cell sarcomas.Nat Rev Dis Primers2022
36301196Epitope Mapping of an Anti-Mouse CXCR6 Monoclonal Antibody (Cx<sub>6</sub>Mab-1) Using the 2⿿ÿ⿿Alanine Scanning Method.Monoclon Antib Immunodiagn Immunother2022
36383113Development of a Sensitive Anti-Human CCR9 Monoclonal Antibody (C<sub>9</sub>Mab-11) by N-Terminal Peptide Immunization.Monoclon Antib Immunodiagn Immunother2022
35947126MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.Blood Adv2022
35225663Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody (134-mG<sub>2a</sub>-f) Exerts Antitumor Activities in Mouse Xenograft Models of Canine Osteosarcoma.Monoclon Antib Immunodiagn Immunother2022
35018934Three-dimensional tissue model in direct contact with an on-chip vascular bed enabled by removable membranes.Lab Chip2022
34381180Trib1 promotes the development of acute myeloid leukemia in a Ts1Cje mouse model of Down syndrome.Leukemia2022
32730594Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9.Blood2021
33877898Development of Anti-Mouse CC Chemokine Receptor 3 Monoclonal Antibodies for Flow Cytometry.Monoclon Antib Immunodiagn Immunother2021
33900818Development of Anti-Mouse CC Chemokine Receptor 8 Monoclonal Antibodies for Flow Cytometry.Monoclon Antib Immunodiagn Immunother2021
33900817Development of Anti-human T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT) Monoclonal Antibodies for Flow Cytometry.Monoclon Antib Immunodiagn Immunother2021
34424763Epitope Mapping of an Anti-Human Epidermal Growth Factor Receptor Monoclonal Antibody (EMab-51) Using the RIEDL Insertion for Epitope Mapping Method.Monoclon Antib Immunodiagn Immunother2021
34424762Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 134-mG<sub>2a</sub>-f Exerts Antitumor Activities in Mouse Xenograft Models of Dog Epidermal Growth Factor Receptor-Overexpressed Cells.Monoclon Antib Immunodiagn Immunother2021
34653294C/EBPβ induces B-cell acute lymphoblastic leukemia and cooperates with BLNK mutations.Cancer Sci2021
34161159Development of Anti-Human CC Chemokine Receptor 9 Monoclonal Antibodies for Flow Cytometry.Monoclon Antib Immunodiagn Immunother2021
34184091Antiâ¿¿HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.Oncol Rep2021
34042540Development of Monoclonal Antibody PMab-269 Against California Sea Lion Podoplanin.Monoclon Antib Immunodiagn Immunother2021
34265156Modeling fusion gene-associated sarcoma: Advantages for understanding sarcoma biology and pathology.Pathol Int2021
33326102Genetically Engineered Mouse Model in Ewing Sarcoma.Methods Mol Biol2021
32349619Development of an Anti-Sheep Podoplanin Monoclonal Antibody PMab-256 for Immunohistochemical Analysis of Lymphatic Endothelial Cells.Monoclon Antib Immunodiagn Immunother2020
32019274Cooperation between SS18-SSX1 and miR-214 in Synovial Sarcoma Development and Progression.Cancers (Basel)2020
33085938Development of Core-Fucose-Deficient Humanized and Chimeric Anti-Human Podoplanin Antibodies.Monoclon Antib Immunodiagn Immunother2020
33125138Antiâ¿¿EpCAM monoclonal antibody exerts antitumor activity against oral squamous cell carcinomas.Oncol Rep2020
32945346Antiâ¿¿EGFR monoclonal antibody 134â¿¿mG2a exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.Int J Mol Med2020
33000243A defucosylated antiâ¿¿CD44 monoclonal antibody 5â¿¿mG2aâ¿¿f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.Oncol Rep2020
32825119Identification of Novel Fusion Genes in Bone and Soft Tissue Sarcoma and Their Implication in the Generation of a Mouse Model.Cancers (Basel)2020
32644843An Antihuman Epidermal Growth Factor Receptor 2 Monoclonal Antibody (H<sub>2</sub>Mab-19) Exerts Antitumor Activity in Glioblastoma Xenograft Models.Monoclon Antib Immunodiagn Immunother2020
32182186Antibody-Drug Conjugates Using Mouse-Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft Model.Monoclon Antib Immunodiagn Immunother2020
32552424An Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H<sub>2</sub>Mab-19 Exerts Antitumor Activity in Mouse Colon Cancer Xenografts.Monoclon Antib Immunodiagn Immunother2020
32240034Epitope Mapping of PMab-241, a Lymphatic Endothelial Cell-Specific Anti-Bear Podoplanin Monoclonal Antibody.Monoclon Antib Immunodiagn Immunother2020
32271687Development of Novel Mouse Monoclonal Antibodies Against Human CD19.Monoclon Antib Immunodiagn Immunother2020
29723111Elucidation of the TMab-6 Monoclonal Antibody Epitope Against Telomerase Reverse Transcriptase.Monoclon Antib Immunodiagn Immunother2019
31403389Characterization of Anti-Goat Podoplanin Monoclonal Antibody PMab-235 Using Immunohistochemistry Against Goat Tissues.Monoclon Antib Immunodiagn Immunother2019
31313968PMab-247 Detects Bear Podoplanin in Immunohistochemical Analysis.Monoclon Antib Immunodiagn Immunother2019
31199696Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H<sub>2</sub>Mab-41 Exerts Antitumor Activity in a Mouse Xenograft Model of Colon Cancer.Monoclon Antib Immunodiagn Immunother2019
31338471PMab-235: A monoclonal antibody for immunohistochemical analysis against goat podoplanin.Heliyon2019
31538390Case of mesenchymal tumor with the PPP6R3-USP6 fusion, possible nodular fasciitis with malignant transformation.Pathol Int2019
30984883Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin.Biochem Biophys Rep2019
31009336Establishment of a Monoclonal Antibody PMab-231 for Tiger Podoplanin.Monoclon Antib Immunodiagn Immunother2019
30832329Pericytes as a Source of Osteogenic Cells in Bone Fracture Healing.Int J Mol Sci2019
30802179PMab-213: A Monoclonal Antibody for Immunohistochemical Analysis Against Pig Podoplanin.Monoclon Antib Immunodiagn Immunother2019
30766925PMab-219: A monoclonal antibody for the immunohistochemical analysis of horse podoplanin.Biochem Biophys Rep2019
  • 1 - 50 of 179

Recommended Authors

Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 2
Ji Zhang
Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 3
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 4
Qingxia Wei
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 2000
Number of shared co-authors 2
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 8
Yi-Jue Zhao
The First Affiliated Hospital of Guangxi Medical University
Career Start Year 1998
Number of shared co-authors 1
Shinichiro Takahashi
Tohoku Medical and Pharmaceutical University Hospital.
Career Start Year 1998
Number of shared co-authors 1
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Sandra Burkett
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 3
Kevin S Smith
Stanford University
Career Start Year 1997
Number of shared co-authors 0
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 6
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 1
Hua Han
He Bei General Hospital
Career Start Year 1991
Number of shared co-authors 1
Dirk Geerts
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 0
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 1
Dong-Er Zhang
Moores Cancer Center, University of California San Diego
Career Start Year 1986
Number of shared co-authors 0
Haruhiko Koseki
RIKEN Research Center for Allergy and Immunology
Career Start Year 1986
Number of shared co-authors 4
David M Loeb
Children's Hospital at Montefiore.
Career Start Year 1986
Number of shared co-authors 8
Tarik M??r??y
Institut de recherches cliniques de Montreal
Career Start Year 1985
Number of shared co-authors 0
David J Adams
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 4
Michael C Ostrowski
Hollings Cancer Center, Medical University of South Carolina
Career Start Year 1979
Number of shared co-authors 1
Hiroshi Handa
Center for Future Medical Research, Tokyo Medical University
Career Start Year 1975
Number of shared co-authors 2
Daniel G Tenen
Harvard Stem Cell Institute, Harvard Medical School
Career Start Year 1975
Number of shared co-authors 2
Alex Look
Dana-Farber Cancer Institute
Career Start Year 1975
Number of shared co-authors 5
Timothy J Triche
Center for Epigenetics, Van Andel Research Institute
Career Start Year 1971
Number of shared co-authors 12

Collaborators

David A Largaespada
University of Minnesota
Co-authored papers 5
John D Shaughnessy
Co-authored papers 3
Yoshiaki Ito
Tokyo Medical and Dental University (TMDU)
Co-authored papers 3
Olivier Delattre
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Co-authored papers 3
Aykut Uren
Georgetown University Medical Center
Co-authored papers 2
Heinrich Kovar
St. Anna Children's Cancer Research Institute (CCRI), Medical University Vienna
Co-authored papers 2
Uta Dirksen
University Hospital Essen, West German Cancer Center
Co-authored papers 2
Enrique de Alava
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Co-authored papers 2
Richard Moriggl
Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna
Co-authored papers 2
James F Amatruda
Children's Hospital of Los Angeles
Co-authored papers 2
Jeffrey A Toretsky
Georgetown University Medical Center, Georgetown University
Co-authored papers 2
Thomas G P Gr??newald
German Cancer Research Center
Co-authored papers 2
Florencia Cidre-Aranaz
Hopp-Children's Cancer Center (KiTZ)
Co-authored papers 2
Franck Tirode
Cancer Center of Lyon
Co-authored papers 2
Katsuya Shigesada
Institute for Virus Research, Kyoto University
Co-authored papers 2
Guy Sauvageau
Universite de Montreal
Co-authored papers 2
Masayuki Yamamoto
Tohoku University Graduate School of Medicine, Tohoku University
Co-authored papers 2
E Alejandro Sweet-Cordero
University of California San Francisco
Co-authored papers 2
Erika Brunet
INSERM UMR 3, Imagine Institute
Co-authored papers 1
Hiromitsu Nakauchi
Advanced Research Institute, Tokyo Medical and Dental University
Co-authored papers 1
Katia Scotlandi
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 1
David H Gutmann
Co-authored papers 1
Qin Su
Co-authored papers 1
Markus Metzler
University Hospital Erlangen
Co-authored papers 1
Stephen L Lessnick
The Ohio State University College of Medicine
Co-authored papers 1
Beat W Sch??fer
Department of Oncology and Children's Research Center, University Children's Hospital
Co-authored papers 1
Maxwell P Lee
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Claudia Rossig
University Children's Hospital Muenster
Co-authored papers 1
Keri Schadler
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Kimberly Stegmaier
Dana-Farber Cancer Institute
Co-authored papers 1
Release 1.2